Every batch of Covaxin subjected to more than 200 quality control tests: Bharat Biotech amid quality concerns
The statement came after reports that test batches of Covaxin from the Bengaluru plant were not satisfactory and got rejected leading to delayed production.
Aug 05, 2021, 23:16 PM ISTAnother milestone! Bharat Biotech’s Covaxin receives GMP compliance certificate from Hungary
Vaccine maker Bharat Biotech announced on Thursday that it`s COVID-19 vaccine, Covaxin, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
Aug 05, 2021, 14:45 PM ISTCovaxin will control 3rd COVID-19 wave, ICMR study reveals major facts
Covaxin is developed indigenously by Bharat Biotech which has shown an overall vaccine efficacy of 77.8% based on the results from the Phase 3 trials.
Aug 02, 2021, 15:30 PM ISTMixing of Covaxin and Covishield shots: Expert panel gives nod for trials
"The Phase 4 trials for mixing doses of Covaxin and Covishield will soon take place soon on healthy 300 volunteers," the expert panel said.
Jul 30, 2021, 07:19 AM ISTSeized COVID vaccine vials not Covishield, Serum Institute tells Kolkata Police
Serum Institute has communicated to Kolkata Police that the seized vials with labels of Covishield vaccine in the fake vaccine case in Kolkata was not Covishield vaccine. For further examination, Kolkata Police has sent those vials to Drug Controller for chemical examination.
Jul 29, 2021, 19:34 PM ISTAIIMS Delhi to start second dose trial of Bharat Biotech’s Covaxin on 2-6 years old children by next week
As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week.
Jul 23, 2021, 06:33 AM ISTBharat Biotech's Covaxin may soon get WHO approval
Bharat Biotech has handed over all the necessary documents related to Covaxin to WHO, after which the vaccine is now expected to get emergency approval.
Jul 13, 2021, 11:10 AM ISTDocuments for emergency use listing of Covaxin submitted to WHO, says Bharat Biotech
A WHO pre-qualification, or a EUL, is necessary for a vaccine company to supply vaccines for global facilities such as Covax or international procurement.
Jul 13, 2021, 07:19 AM ISTBharat Biotech's Covaxin may get Emergency Use List approval soon, here's what WHO said
World Health Organization may take the decision to include Bharat Biotech's COVID-19 vaccine Covaxin to emergency use list (EUL) within four to six weeks chief scientist Soumya Swaminathan said.
Jul 10, 2021, 18:42 PM ISTAs Moderna readies to make an entry into India, list of other COVID-19 vaccine options available
Prime Minister Narendra Modi, has hinted that the supply of COVID-19 vaccines is about to increase in the coming days.
Jul 03, 2021, 23:42 PM ISTNews 50: Watch top 50 news stories of the day
In this section, you will find the top news stories of the day. Segment News 50 is a part of Zee News important news bulletins in which we cover all the important news.
Jul 03, 2021, 15:50 PM ISTCOVID-19: Covaxin is also effective against Delta variant!
Bharat Biotech has released safety and efficacy analysis data from Phase III clinical trials of Covaxin. Watch the report to know more.
Jul 03, 2021, 14:08 PM ISTCovaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials
Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19.
Jul 03, 2021, 06:02 AM ISTOdisha requests Centre to allocate 17 lakh vaccine doses not lifted by private hospitals
Odisha is losing a huge quantity of vaccines allocated for private hospitals in the state as the centre distributed the vaccines in the ratio of 75:25 between the government and the private facilities.
Jul 02, 2021, 23:16 PM ISTAny vaccine is better than no vaccine, says Estonia envoy
Estonia's envoy Katrin Kivi said, "India has been giving so many vaccines to Indians and to Covax. It would be absolutely natural that Covishield will get recognition by WHO and EMA".
Jul 02, 2021, 10:27 AM ISTAllow Indians vaccinated with Covishield, Covaxin to travel to Europe: India tells EU nations
India has requested the members of the European Union to individually consider allowing Indians who have taken Covishield and Covaxin vaccines to travel to Europe.
Jun 30, 2021, 21:34 PM ISTCovaxin deal: Bharat Biotech denies allegations of irregularities, says no advance payment received from Brazil
Brazilian federal prosecutors have opened an investigation into the Covaxin deal, citing comparatively high prices, quick talks and pending regulatory approvals as red flags for the contract signed in February.
Jun 30, 2021, 14:09 PM ISTBrazil suspends Bharat Biotech’s Covaxin order over graft allegations
The Bharat Biotech has said that the pricing of COVAXIN has been clearly established between USD 15-20 per dose for supplies to Governments outside India.
Jun 30, 2021, 11:44 AM ISTBharat Biotech's Covaxin Coronavirus vaccine may soon get WHO recognition
COVID-19 vaccine 'Covaxin' developed in India moves one more step closer to World Health Organization (WHO) approval. The global health body said on Tuesday that rolling data would start in July, following a pre-submission meeting with Bharat Biotech held on June 23.
Jun 30, 2021, 08:22 AM ISTCovaxin 'effectively' neutralizes Alpha and Delta variants of COVID-19: America's NIH
The Alpha and Delta variants of COVID-19 were first identified in the United Kingdom and India, respectively.
Jun 30, 2021, 06:27 AM IST